PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33380704-6	2020	Results: : Both candesartan and atorvastatin treated groups showed significant decrease in serum levels IL-1beta and TNF-alpha, acute-phase reactants (CRP and ESR), number of swollen joint and patient global assessment.	Atorvastatin	32-44	interleukin 1 alpha	Homo sapiens	104-112	
15488879-8	2004	The use of atorvastatin when compared to diet alone, resulted in significant (P <0.0001) reductions for: LDL-cholesterol (39.9% versus 4.4%), TNF (21.4% versus 2.9%), IL-6 (22.1% versus 2.0%), IL-1 (16.4% versus 2.7%) and sICAM-1 (9.6% versus 0.1%), respectively.	Atorvastatin	11-23	interleukin 1 alpha	Homo sapiens	196-200	
29142375-9	2017	Reduced levels of IL-1, IL-6, TNF-alpha, IFN, and CRP were observed in the atorvastatin group.	Atorvastatin	75-87	interleukin 1 alpha	Homo sapiens	18-22	
17070781-6	2007	Atorvastatin also downregulated interleukin-1alpha (IL-1alpha)-induced OPG production in endothelial cells.	Atorvastatin	0-12	interleukin 1 alpha	Homo sapiens	32-50	
17070781-6	2007	Atorvastatin also downregulated interleukin-1alpha (IL-1alpha)-induced OPG production in endothelial cells.	Atorvastatin	0-12	interleukin 1 alpha	Homo sapiens	52-61	
15488879-10	2004	CONCLUSION: In hypercholesterolemic patients, atorvastatin, compared to diet alone resulted in significant reductions in levels of proinflammatory cytokines (TNF, IL-1 and IL-6) as well as in sICAM-1 and CRP.	Atorvastatin	46-58	interleukin 1 alpha	Homo sapiens	163-167	
35335908-4	2022	The biochemical analysis indicated that either alcohol or ATOR or together in combination produced a significant increase in the nucleotide-binding domain-like receptor 3 (NLRP3), interleukin-1beta (IL-1beta) miRNA155 expression levels in the frontal cortex of the brain tissue.	Atorvastatin	58-62	interleukin 1 alpha	Homo sapiens	199-207	
15051633-7	2004	(1) Although mRNA levels of IL-1alpha and IL-1beta were markedly reduced in PBMCs from CAD patients after 6 months of simvastatin (20 mg/d, n=15) and atorvastatin (80 mg/d, n=15) therapy, the reduction in IL-1 receptor antagonist (IL-1Ra) was more modest.	Atorvastatin	150-162	interleukin 1 alpha	Homo sapiens	28-37